My wife has gone up to Ct already without me. So pissed. The pool guys are going to be putting in a new heater. At least she can't swim. Not off to a good start with the Summer Bills. Stifel ups price target for 'most compelling' theme park Six Flags to $59 07:20 SIX Stifel analyst Steven Wieczynski raised the firm's price target on Six Flags to $59 from $57 and keeps a Buy rating on the shares, which he calls "the most compelling name under our coverage" coming out of the Q1 earnings reporting season for the theme park operators. Shares are down 15% since the company reported on April 28, but Wieczynski believes the selloff is unwarranted, he tells investors. He believes there are three near-term catalysts that can push shares higher over the next four to five months as he thinks there could be material upside to 2021/2022 estimates, while he also sees long-term catalysts that should push shares higher over the next couple of years, the analyst said.
Well, I guess I'm a dummy then because I can't keep track of what's just an idea, an analyst upgrade, an add..... whatever. Yes we're lucky to have you and you're the greatest. T-Shirt on the way. Moving on here.... Women's hair loss Stoney. Big money. Telemeds. Big money. High option volume... big money. Insider buys... big money.... And what do we get? $LFMD $12.34 ---------------------------------- NEW YORK, May 18, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced partnerships with internationally acclaimed actresses Kate del Castillo and Bellamy Young. Through virtual visits with LifeMD medical professionals, they successfully treated their hair loss using Shapiro MD™ products. The partnerships announced today will include global online and offline advertising campaigns in which the stars will share their personal hair-restoration journeys and successes using Shapiro MD’s prescription and over the counter products for female hair loss. “We are extremely pleased to have Kate and Bellamy join the LifeMD family. We are touched that they have partnered with us and agreed to share their personal experiences and successes using Shapiro MD’s telemedicine offering for hair loss,” said Dr. Anthony Puopolo, Chief Medical Officer of LifeMD. “These campaigns will spotlight the very real problem of female hair loss – which affects more than 50% of the population – to Kate and Bellamy’s large and global fan base.” Added Kate del Castillo, “With such a busy production schedule, it’s not always possible for me to visit specialists while away on set and filming. Using Shapiro MD™ products has been incredibly convenient and effective – and has allowed me to get the care that I need.” “Having a personal treatment plan created by a licensed medical provider has been reassuring. And the effective products that have been delivered to me by mail have really taken the complication out of seeking treatment for something so personal such as hair loss,” said Bellamy Young. “I believe a lot of people would benefit from knowing about Shapiro MD™ and its telemedicine offering for hair loss.” About Kate del Castillo Kate del Castillo is the star of the acclaimed and #1 watched series in the history of Telemundo, La Reina Del Sur; and will soon begin production of the highly anticipated third season. She recently completed another Telemundo series, Armas De Mujer, which will air on NBC's Peacock streaming platform. Last year, Kate starred opposite Will Smith as the main antagonist in Sony's hit film Bad Boys for Life. During quarantine, she also wrote, starred, and directed an episode of Peacock's At-Home Variety Show, hosted by Seth MacFarlane. Kate previously recurred on Jane the Virgin for CW and guest starred on NBC's Telenovela, among other hit films. In 2019, del Castillo returned to the New York stage for the off-Broadway production of her one-woman show The Way She Spoke. Kate’s performance earned a Drama Desk nomination for Outstanding Solo Performance. Kate is a global social media influencer and has more than 12 million followers across her Instagram, Facebook, and Twitter channels.
LifeMD is a direct-to-patient telehealth company that provides a smarter, cost-effective and convenient way of accessing healthcare. We believe the traditional model of visiting a doctor’s office, receiving a physical prescription, visiting a local pharmacy, and returning to see a doctor for follow up care or prescription refills is inefficient, costly to patients, and discourages many patients from seeking much needed medical care. The U.S. healthcare system is undergoing a paradigm shift, thanks to new technologies and the emergence of direct-to-patient healthcare. Direct-to-patient telemedicine companies, like our company, connect consumers to licensed healthcare professionals for care across numerous indications, including concierge care, men’s sexual health and dermatology, among others. Our telemedicine platform helps patients access licensed providers for diagnoses, virtual care, and prescription medications, often delivered on a recurring basis. In addition to our telemedicine offerings, we sell nutritional supplements and other over-the-counter products. Many of our products are available on a subscription or membership basis, where a patient can subscribe to receive regular shipments of prescribed medications or products. This creates convenience and often discounted pricing opportunities for patients and recurring revenue streams for us. Our patient acquisition strategy combines strategic brand-building media placements and direct response advertising methods across highly scalable marketing channels (i.e. national TV, streaming TV, streaming audio, podcast, print, magazines, online search, social media, and digital). Since inception, we have helped more than 300,000 customers and patients, providing them greater access to high-quality, convenient, and affordable care in all 50 states. Our telemedicine revenue increased 208% in 2020 vs. the prior year. Total revenue from recurring subscriptions is approximately 80%. In addition to our telehealth business, we own 85.6% of PDFSimpli, a rapidly growing SaaS platform for converting, signing, editing and sharing PDF documents. This business has also seen 165% year over year growth, with recurring revenue of 100%.
--- Like my wife told me-- Dropbox: The Right Stock To Bank On In A Tech Downturn Summary Shares of Dropbox are defying malaise in the rest of the tech sector, up ~20% year-to-date. The company just reported a Q1 earnings beat that overachieved on revenue while showing massive expansion in operating margins. A recent acquisition called DocSend should accelerate Dropbox's penetration into the enterprise segment. The stock is appealingly priced at <5x forward revenue.
Well, I guess I'm a dummy then because I can't keep track of what's just an idea, an analyst upgrade, an add..... whatever. That's why I invented the gummys. I usually just invest long ideas for the long run. But when I'm on ET I always follow the market every day. Since I'm home without a job (they call it retired) I also do some short term trades and even day trades. What I tend to do is buy the same stock a few ways I'll take a scalp and I'll also hold to the position ... I will also just buy and sell daily ideas I don't care that much about simply because they are moving. I have found through many many years of experience that my method is best. I used to follow a ton of stocks and then I would think myself so smart with my RS lines and my moving averages, MACD! and my volume alerts and you know what? I was in a lot of dead wood. Too much paper trail, too many stocks that quickly reversed. I realized I need to day play with ideas that lots of other people are looking at... that's the only way to get the type of response that I want which typically is a quick open and a retrace. That's when I buy. So I peruse the upgrades to find ideas I think will appeal to other investors... I mean I do like the 6 flags idea and I endorse it. Usually the stocks I post on I have some inkling about or favortism towards for that's why i choose them. But I also think about the wider audience here at ET and that's why I highlight "IRA "plays etc. I also will have a group of twenty or so names in my head at all times and will use a "Rule Of 3" " which is if I hear a guy on TV talk about the stk and I see an upgrade from some house and I on my own find something, an EPS raise or Insider buy, when I gather 3 positives that triggers a buy for LT. Have you looked at SPRO...
And look at the rising cost: Data by YCharts In Q4, operating expenses jumped to a whopping $41.2M from just $3.7M a year ago with S&M increasing by $15.2M and G&A increasing by $21.7M. Outlook Management forecasts revenue between $85M and $95M (+128%-+155% y/y). SUPER CHART READ VAN!- This is a little old but that $14.50 will be ceiling an or Break out!-- You have a free $2! LFMD LifeMD, Inc. 12.13 1.80(+17.43%)<------ why up big yesterday? 4:00 PM 05/20/21 Pre-Market:$12.84+0.71(+5.85%)8:20 AM This could go to $20!
Van stk was $9.70 when they did this-> LifeMD files to sell 608.7K shares of common stock for holders 04/28 LFMD I have not seen them come to market though.... A neg) on 4/27 passive stake taken--> Millennium Management reports 4.8% passive stake in LifeMD 04/27 LFMD Israel Englander's Millennium Management disclosed last night a 4.8% stake in LifeMD, representing over 1.25M shares. The filing with the SEC is for a passive stake and does not allow for activism. LifeMD shares are down 15c to $9.40 in early trading. Passive stake -= 1. Of Rule Of 3)))))) 4/27 Upgrade--> LifeMD 40% pullback brings 'opportunistic entry point,' says B. Riley 04/27 LFMD B. Riley analyst Andrew D'Silva views the recent pullback in shares of LifeMD as an "opportunistic entry point." He reiterates a Buy rating on the shares with a $35 price target after hosting a chat with management. The stock is down 40% year-to-date as an "anonymous short report has led to the dislocation," D'Silva tells investors in a research note. He says his talk with management confirmed his thoughts, which is that points highlighted within the short report appear to "either provide inaccurate information, conflate opinions and facts, and/or were based on half-truths that left out material context around key points of contention." Upgrade = 2. Of Rule Of Three) ) ) Just need 1 more reason to TRIGGER A BUY!!!! Loving the idea Van.
This just isn't good enough- Tuesday LifeMD enters partnerships with actresses Kate del Castillo, Bellamy Young 08:10 LFMD LifeMD announced partnerships with actresses Kate del Castillo and Bellamy Young. Through virtual visits with LifeMD medical professionals, they treated their hair loss using Shapiro MD products. The partnerships will include global online and offline advertising campaigns in which the stars will share their personal hair-restoration journeys and successes using Shapiro MD's prescription and over the counter products for female hair loss.
Corey Deutsch Is The Chief Business Officer of LifeMD, Inc. (NASDAQ:LFMD) And They Just Picked Up 46% More Shares Simply Wall St Fri, May 21, 2021, 1:43 AM PotentialLifeMD, Inc.(NASDAQ:LFMD) shareholders may wish to note that the Chief Business Officer, Corey Deutsch, recently bought US$199k worth of stock, paying US$8.85 for each share. That's a very decent purchase to our minds and it grew their holding by a solid 46%. Is this why it moved yesterday Van? Is this the final point for a RULE of 3?)))
Why is it the more you look the more you find... BOSTON, MA / ACCESSWIRE / May 12, 2021 /The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of LifeMD, Inc. (NASDAQ:LFMD). The case is currently in the lead plaintiff stage. Investors who purchased LFMD stock or other securities between January 19, 2021 and April 13, 2021 may contact the Thornton Law Firm's investor protection team The case alleges that LifeMD and its senior executives made misleading statements to investors and failed to disclose that: (1) many of LifeMD's executives were associated with Redwood Scientific Technologies, Inc. when it was charged for unlawful autoshipping, abusive telemarketing, and false claims, and that they employed similar practices at LifeMD; (2) LifeMD engaged in autoshipping products to unwilling customers to record recurring revenue and LifeMD made it difficult to cancel such subscriptions; (3) certain of the purportedly licensed physicians on LifeMD's platform were not in fact licensed and faced disciplinary action; and (4) as a result of the foregoing practices, LifeMD was reasonably likely to face regulatory scrutiny and reputational harm. Interested LifeMD investors have until June 15, 2021 to retain counsel